We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRU icon
2426
Spruce Power Holding Corp
SPRU
$38.9M
-1,170
Closed -$18.6K
SRRK icon
2427
Scholar Rock
SRRK
$6.55B
-1,858
Closed -$23.9K
STKS icon
2428
The ONE Group
STKS
$56.5M
-1,401
Closed -$14.7K
TCMD icon
2429
Tactile Systems Technology
TCMD
$555M
-1,313
Closed -$26.5K
THC icon
2430
Tenet Healthcare
THC
$21.5B
-6,646
Closed -$571K
TNYA icon
2431
Tenaya Therapeutics
TNYA
$171M
-2,194
Closed -$25.8K
TOON icon
2432
Kartoon Studios
TOON
$38.7M
-629
Closed -$6.41K
TTEK icon
2433
Tetra Tech
TTEK
$9.09B
-16,825
Closed -$555K
UA icon
2434
Under Armour Class C
UA
$2.2B
-13,078
Closed -$203K
UAA icon
2435
Under Armour
UAA
$2.26B
-11,472
Closed -$195K
VKTX icon
2436
Viking Therapeutics
VKTX
$3.97B
-4,757
Closed -$14.3K
VSTM icon
2437
Verastem
VSTM
$629M
-1,017
Closed -$17.2K
WCC
2438
WESCO International
WCC
$17.8B
-2,780
Closed -$362K
WSC icon
2439
WillScot Mobile Mini Holdings
WSC
$4B
-12,849
Closed -$503K
LENZ
2440
LENZ Therapeutics
LENZ
$158M
-337
Closed -$12K
RPT
2441
Rithm Property Trust
RPT
$99.9M
-234
Closed -$16.4K
EXE
2442
Expand Energy Corp
EXE
$22.3B
-6,460
Closed -$562K
PAMT
2443
PAMT Corp
PAMT
$279M
-484
Closed -$16.8K
KLRS
2444
Kalaris Therapeutics
KLRS
$93.8M
-86
Closed -$13.4K
CMRX
2445
DELISTED
Chimerix, Inc.
CMRX
-4,986
Closed -$22.8K
GATO
2446
DELISTED
Gatos Silver, Inc.
GATO
-3,941
Closed -$17K
SWN
2447
DELISTED
Southwestern Energy Company
SWN
-63,401
Closed -$455K
GTHX
2448
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-2,729
Closed -$20.7K
CONN
2449
DELISTED
Conn's Inc.
CONN
-975
Closed -$15K
DMTK
2450
DELISTED
DermTech, Inc. Common Stock
DMTK
-1,598
Closed -$23.5K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.